🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,39 USD

Máx. histórico

61,25

1786 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-52,02%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-0,20%

Cierre anterior

29,88

Rango de hoy

28,54 – 29,43

Volumen hoy

48.232.765

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,99 (puede no estar actualizado)
Dividend yield
5,76% (puede no estar actualizado)
Precio objetivo analistas
29,72 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 1 día
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,2900 USD · Yield: 4,39%
Fecha de pago Importe por participación
09/05/2000 0,0854 USD
16/02/2000 0,0854 USD
09/11/1999 0,0759 USD
04/08/1999 0,0759 USD
05/05/1999 0,0696 USD
10/02/1999 0,0696 USD
04/11/1998 0,0601 USD
05/08/1998 0,0601 USD
06/05/1998 0,0601 USD
04/02/1998 0,0601 USD
05/11/1997 0,0538 USD
30/07/1997 0,0538 USD
07/05/1997 0,0538 USD
05/02/1997 0,0538 USD
06/11/1996 0,0474 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/11/1999 32,38 33,33 32,02 33,21 +3,70% 4,03% 14.965.008
19/11/1999 31,84 32,44 31,72 32,02 +0,19% 2,23% 14.863.297
18/11/1999 32,85 32,91 31,61 31,96 -0,37% 3,97% 18.136.073
17/11/1999 32,50 32,97 31,84 32,08 -0,18% 3,47% 19.881.602
16/11/1999 33,56 34,01 32,14 32,14 -3,21% 5,57% 19.782.526
15/11/1999 33,33 33,56 32,79 33,21 -0,36% 2,31% 13.329.622
12/11/1999 33,86 33,92 33,15 33,33 -0,71% 2,28% 10.916.700
11/11/1999 34,10 34,10 33,21 33,56 +1,07% 2,61% 9.516.461
10/11/1999 33,21 33,59 32,32 33,21 +0,00% 3,84% 16.213.471
09/11/1999 33,21 33,44 32,91 33,21 +0,72% 1,61% 22.277.239
08/11/1999 32,97 33,68 32,73 32,97 +0,00% 2,88% 22.576.996
05/11/1999 34,39 34,39 32,50 32,97 -6,71% 5,52% 46.771.355
04/11/1999 36,65 37,06 35,10 35,34 -3,40% 5,34% 14.825.037
03/11/1999 37,00 37,30 36,41 36,59 +1,15% 2,40% 7.498.578
02/11/1999 36,65 37,24 36,17 36,17 -0,97% 2,91% 6.981.485
01/11/1999 37,48 37,95 36,53 36,53 -2,99% 3,80% 7.434.073
29/10/1999 37,95 38,01 37,42 37,65 -0,16% 1,56% 10.528.722
28/10/1999 37,24 37,89 36,82 37,71 +3,25% 2,87% 10.946.422
27/10/1999 35,40 36,59 35,34 36,53 +4,05% 3,52% 8.216.246
26/10/1999 37,48 37,54 35,10 35,10 -7,50% 6,49% 10.137.583
25/10/1999 37,71 38,07 35,99 37,95 -3,90% 5,50% 15.732.742
22/10/1999 39,85 39,97 39,14 39,49 -0,30% 2,08% 9.235.043
21/10/1999 38,84 40,09 38,48 39,61 +0,60% 4,12% 16.516.496
20/10/1999 37,95 39,37 37,77 39,37 +3,91% 4,22% 18.243.897
19/10/1999 36,59 37,95 36,53 37,89 +6,32% 3,89% 15.497.911
18/10/1999 34,75 35,93 34,75 35,64 +1,86% 3,41% 6.921.196
15/10/1999 34,99 35,52 34,69 34,99 -2,16% 2,37% 6.158.733
14/10/1999 35,76 36,17 35,52 35,76 -0,82% 1,82% 5.050.030
13/10/1999 37,00 37,06 35,88 36,05 -3,49% 3,21% 7.001.511
12/10/1999 37,71 37,71 37,12 37,36 -1,10% 1,57% 7.517.128